Initiated clinical trial with novel nasal spray codenamed APR-...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BALERNA, Switzerland, May 14, 2021 /PRNewswire-AsiaNet/ -- Product recently cleared in EU as Class III medical deviceAPR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the...
Authors: LATEST ASIANET NEWS RELEASES